JBCHEPHARM (J.B. Chemicals & Pharmaceuticals Ltd.): Acquisition / M&A

Strota Newsroom · session of 2026-07-07 · 07 Jul 20:06 · JBCHEPHARM stock page →

JB Chemicals & Pharmaceuticals Limited has informed the Exchange that Record date for the purpose of Merger/HiveOff is… Historically, acquisition / m&a events have moved JBCHEPHARM-type stocks in the bullish direction 48.9% of the next sessions (n=141).

J.B. Chemicals & Pharmaceuticals Ltd. has set 17 July 2026 as the record date for its merger with Torrent Pharmaceuticals, according to an NSE filing dated 7 July. The announcement marks a procedural step in the amalgamation that has already received National Company Law Tribunal approval. The stock closed at ₹2,422 on 7 July, up 1.34% from the previous session and extending its winning streak to five consecutive trading days.

Events like this—acquisition or merger record-date announcements—have historically shown a 48.9% win rate across 141 comparable instances in Strota's database, with a net edge of 0.213 percentage points. These figures represent base rates for the event type, not a forecast for this specific transaction.

The counter currently trades at 54.49 times trailing earnings and 9.35 times book value, with a market capitalisation of ₹38,887 crore. Relative volume stood at 3.31 times the 20-day average, while the 14-day RSI of 80.1 indicates technically overbought conditions. The stock sits 0.28% below its 52-week high of ₹2,428.8 and has gained 24.68% over the past three months.

The data establishes that the record date has been fixed and that the stock has outperformed the Nifty's 0.13% decline on the announcement day. It does not establish the likelihood of scheme completion, the final swap ratio outcome, or whether current valuations already reflect merger terms.

The catalyst

JB Chemicals & Pharmaceuticals Limited has informed the Exchange that Record date for the purpose of Merger/HiveOff is 17-Jul-2026. (filing · NSE)

What the data shows after this event

Across Strota's backtest of past filings, Acquisition / M&A shows no reliable next-session edge — the move went bullish in about 48.9% of next sessions (net 0.213% after drift and cost, n=141). A base rate, not a forecast for this stock.

JBCHEPHARM right now

trading +1.34% on the day; P/E 54.49; RSI 80.1. Full JBCHEPHARM analysis →

Sources

Keep digging

How this article was made: Strota assembled the exchange data above (prices, F&O open interest, bulk/block deals, SEBI PIT filings, indicator readings and public headlines) and an AI model wrote the narrative strictly from that evidence — it is not permitted to add outside facts or numbers. Every figure comes from the underlying exchange/public data.